bioAffinity Technologies (BIAFW) Other Operating Expenses (2021 - 2026)

bioAffinity Technologies (BIAFW) has 6 years of Other Operating Expenses data on file, last reported at -$2.7 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$2.7 million, down 79.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $962901.0 (down 72.64% YoY), and the FY2025 annual result was $5.3 million, down 21.95% from the prior year.
• Other Operating Expenses declined to -$2.7 million in Q1 2026 per BIAFW's latest filing, from $1.3 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $1.8 million in Q4 2024 and troughed at -$2.7 million in Q1 2026.
• A 5-year average of $490190.0 and a median of $193600.0 in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses jumped 10351.86% in 2023, then tumbled 186.3% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at -$16999.0 in 2022, then jumped by 10351.86% to $1.7 million in 2023, then grew by 3.32% to $1.8 million in 2024, then decreased by 28.85% to $1.3 million in 2025, then slumped by 309.75% to -$2.7 million in 2026.
• Business Quant data shows BIAFW's Other Operating Expenses at -$2.7 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.